Author(s): Parkinson DR, Ziegler J
Abstract Share this page
Abstract The personalized-medicine concept represents the future of oncology medicine. New genomics technologies will characterize patients biologically in ways that will drive more efficient and effective cancer treatment. Yet the introduction of these technologies is disruptive to current practices in clinical oncology, as well as to current regulatory and reimbursement strategies. The efficient introduction of personalized medicine will require education in addition to behavioral and policy changes by the various involved stakeholders.
This article was published in Clin Pharmacol Ther
and referenced in Journal of Entrepreneurship & Organization Management